Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04013789 · ClinicalTrials.gov registry record · NA

Comparison of Two Daily Disposable Lenses

A NA study of Myopia and Refractive Ametropia, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
79
Enrollment target
1
Study location

NCT04013789 is a NA study of Myopia and Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 79 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04013789, a NA study of Myopia and Refractive Ametropia, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare the clinical performance of the new DAILIES® AquaComfort PLUS® FreshTech (DACP FreshTech) contact lenses to an already marketed daily disposable contact lens, DAILIES® AquaComfort PLUS® (DACP).

Interventions

  • DEVICE DACP FreshTech contact lenses
  • DEVICE DACP contact lenses

Study Locations (1)

Indiana

  • Alcon Investigative Site - Bloomington

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2019-08-27
Est. Completion 2019-11-22
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT04013789

The ClinicalTrials.gov registry entry for NCT04013789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which DACP FreshTech contact lenses is the first listed.

NCT04013789 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04013789 about?

NCT04013789 is a clinical study titled "Comparison of Two Daily Disposable Lenses". The purpose of this study was to compare the clinical performance of the new DAILIES® AquaComfort PLUS® FreshTech (DACP FreshTech) contact lenses to an already marketed daily disposable contact lens, DAILIES® AquaComfort PLUS® (DACP).

What is the current status of trial NCT04013789?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2019-08-27. Estimated completion is 2019-11-22.

What conditions does trial NCT04013789 study?

This clinical trial studies the following conditions: Myopia, Refractive Ametropia.

What interventions are being tested in trial NCT04013789?

The interventions under investigation include: DACP FreshTech contact lenses (DEVICE), DACP contact lenses (DEVICE).

Who is sponsoring clinical trial NCT04013789?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04013789 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.